Ajanta Pharma gets USFDA approval for Omeprazole and Sodium Bicarbonate powder

Ajanta Pharma Limited announces the receipt of final approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension from USFDA.

July 29, 2016 / 10:41 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Ajanta Pharma Ltd has informed BSE regarding a Press Release dated July 29, 2016 titled "Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension".Source : BSE

Read all announcements in Ajanta Pharma

first published: Jul 29, 2016 10:41 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347